A Tale of Two Cities: Gold vs Biotechs

The below guest post comes to us from AllAboutTrends.com

David reached out to me with his take on how low the price of gold could actually sink to. He sees it as the mirror image of the biotech sector right now, an area I am invested in that could be making a climax top. I thought the juxtaposition was an interesting one. 

Harlan Pyan and David Grandey are the founders and owners of All About Trends, a subscription based newsletter service focused on helping individuals secure consistent profits in the market by buying leading stocks at alternative entry points and trading what they see – not what they think, hear or fear.

I hope you enjoy it! – JB



How Low Can Gold Go?

There is an old saying that applies today and that is:

Wear em out or scare em out!

It doesn’t take a rocket scientist to see which it is with GLD:



Much like the bios are looking like climax runs as shown below:

Chart Chart

With gold, we see the flip side of a climax run is a capitulation low. And when we look at gold, it sure is looking like a capitulation here. What do climax runs and capitulations have in common? Both mark the beginning of the end. In climax runs that end is the end of running up, in capitulations that end is the end of going down.  It doesn’t happen in a day mind you but call both the bios and GLD in the zone.


When zooming out to a bigger chart you can see areas of support as shown by the blue lines that are fast approaching.

Long term gold holders? You might as well gut it out for a bit here. Might be a bit of a roller coaster but there is also a higher level to consider walking away if your courage of conviction is getting tested here and that would be on a bounce up to the 148-150 level.


Thanks David and Harlan!


All About Trends

 Follow them on Twitter @allabouttrends


This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

Wealthcast Media, an affiliate of Ritholtz Wealth Management, receives payment from various entities for advertisements in affiliated podcasts, blogs and emails. Inclusion of such advertisements does not constitute or imply endorsement, sponsorship or recommendation thereof, or any affiliation therewith, by the Content Creator or by Ritholtz Wealth Management or any of its employees. Investments in securities involve the risk of loss. For additional advertisement disclaimers see here: https://www.ritholtzwealth.com/advertising-disclaimers

Please see disclosures here.

What's been said:

Discussions found on the web
  1. sex commented on Sep 18

    … [Trackback]

    […] Information to that Topic: thereformedbroker.com/2013/04/15/a-tale-of-two-cities-gold-vs-biotechs/ […]

  2. immediate edge reviews commented on Sep 22

    … [Trackback]

    […] Here you can find 98708 additional Info to that Topic: thereformedbroker.com/2013/04/15/a-tale-of-two-cities-gold-vs-biotechs/ […]

  3. bitcoin era news commented on Sep 25

    … [Trackback]

    […] Read More Information here to that Topic: thereformedbroker.com/2013/04/15/a-tale-of-two-cities-gold-vs-biotechs/ […]

  4. british dragon pharmaceuticals canada commented on Oct 21

    … [Trackback]

    […] Read More Info here on that Topic: thereformedbroker.com/2013/04/15/a-tale-of-two-cities-gold-vs-biotechs/ […]

  5. Earn Fast Cash Now commented on Nov 03

    … [Trackback]

    […] Information to that Topic: thereformedbroker.com/2013/04/15/a-tale-of-two-cities-gold-vs-biotechs/ […]

  6. td online banking commented on Nov 10

    … [Trackback]

    […] Find More on that Topic: thereformedbroker.com/2013/04/15/a-tale-of-two-cities-gold-vs-biotechs/ […]

  7. fake rolex for sales in singapore commented on Nov 25

    … [Trackback]

    […] Find More to that Topic: thereformedbroker.com/2013/04/15/a-tale-of-two-cities-gold-vs-biotechs/ […]

  8. online dumps shop commented on Dec 23

    … [Trackback]

    […] Information to that Topic: thereformedbroker.com/2013/04/15/a-tale-of-two-cities-gold-vs-biotechs/ […]

  9. tangerine login commented on Jan 13

    … [Trackback]

    […] Information on that Topic: thereformedbroker.com/2013/04/15/a-tale-of-two-cities-gold-vs-biotechs/ […]